Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Instem Wins Contract With US's WIL Research Laboratories

1st May 2014 11:02

LONDON (Alliance News) - Healthcare IT company Instem PLC said Thursday it had won a contract with the US's WIL Research Laboratories LLC to replace its existing study management systems at its sites.

Under the contract, Ashland, Ohio-based WIL Research has chosen Instem's Provantis software suite to replace its existing systems, and selected Instem's Centrus-Submit software, in order to meet the new standard reporting format for nonclinical data.

No financial details were disclosed.

"WIL's selection of Instem's technology to replace all of its existing study management systems is a significant endorsement of the quality of our solutions," said Chief Executive Office Phil Reason in a statement.

Shares in Instem were trading down 0.9% at 175.00 pence Thursday morning.

By Hana Stewart-Smith; [email protected]; @HanaSSAllNews

Copyright 2014 Alliance News Limited. All Rights Reserved.


Related Shares:

INS.L
FTSE 100 Latest
Value8,809.74
Change53.53